 | Up a level |
Betsch, BY; Eggli, S; Siebenrock, KA; Täuber, MG; Mühlemann, K (2008). Treatment of joint prosthesis infection in accordance with current recommendations improves outcome. Clinical infectious diseases, 46(8), pp. 1221-6. Cary, N.C.: The University of Chicago Press 10.1086/529436
Rossi, M; Zimmerli, W; Furrer, H; Zanetti, G; Mühlemann, K; Täuber, MG; Schweizerische, Gesellschaft für Infektiologie (2005). [Antibiotic prophylaxis for late blood-borne infections of joint prostheses]. Schweizerische Monatsschrift für Zahnmedizin, 115(6), pp. 571-9. Bern: Schweizerische Zahnärzte-Gesellschaft
Evison, J; Täuber, MG; Mühlemann, K (2005). [Acute infectious emergencies in adults in medical practice]. Therapeutische Umschau, 62(6), pp. 351-7. Bern: Huber
Mühlemann, K; Wenger, C; Zenhäusern, R; Täuber, MG (2005). Risk factors for invasive aspergillosis in neutropenic patients with hematologic malignancies. Leukemia, 19(4), pp. 545-50. Basingstoke: Nature Publishing Group 10.1038/sj.leu.2403674
Jiang, X; Mu, D; Manabat, C; Koshy, AA; Christen, S; Täuber, MG; Vexler, ZS; Ferriero, DM (2004). Differential vulnerability of immature murine neurons to oxygen-glucose deprivation. Experimental neurology, 190(1), pp. 224-32. San Diego, Calif.: Elsevier 10.1016/j.expneurol.2004.07.010
Sheldon, RA; Jiang, X; Francisco, C; Christen, S; Vexler, ZS; Täuber, MG; Ferriero, DM (2004). Manipulation of antioxidant pathways in neonatal murine brain. Pediatric research, 56(4), pp. 656-62. New York, N.Y.: Nature Publishing Group 10.1203/01.PDR.0000139413.27864.50
Kim, YS; Honkaniemi, J; Sharp, FR; Täuber, MG (2004). Expression of proinflammatory cytokines tumor necrosis factor-alpha and interleukin-1beta in the brain during experimental group B streptococcal meningitis. Molecular brain research, 128(1), pp. 95-102. Amsterdam: Elsevier 10.1016/j.molbrainres.2004.06.009
Zellweger, C; Bodmer, T; Täuber, MG; Mühlemann, K (2004). Failure of ceftriaxone in an intravenous drug user with invasive infection due to Ralstonia pickettii. Infection, 32(4), pp. 246-8. Heidelberg: Urban & Vogel 10.1007/s15010-004-3033-0
Cottagnoud, PH; Täuber, MG (2004). New therapies for pneumococcal meningitis. Expert opinion on investigational drugs, 13(4), pp. 393-401. London: Informa Healthcare 10.1517/13543784.13.4.393
Marchetti, O; Bille, J; Fluckiger, U; Eggimann, P; Ruef, C; Garbino, J; Calandra, T; Glauser, MP; Täuber, MG; Pittet, D; Fungal, Infection Network of Switzerland (2004). Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clinical infectious diseases, 38(3), pp. 311-20. Cary, N.C.: The University of Chicago Press 10.1086/380637
Cottagnoud, P; Gerber, CM; Majcherczyk, PA; Acosta, F; Cottagnoud, M; Neftel, K; Moreillon, P; Täuber, MG (2003). The stereochemistry of the amino acid side chain influences the inflammatory potential of muramyl dipeptide in experimental meningitis. Infection and immunity, 71(6), pp. 3663-6. New York, N.Y.: American Society for Microbiology 10.1128/IAI.71.6.3663-3666.2003
Cottagnoud, P; Pfister, M; Cottagnoud, M; Acosta, F; Täuber, MG (2003). Activities of ertapenem, a new long-acting carbapenem, against penicillin-sensitive or -resistant pneumococci in experimental meningitis. Antimicrobial agents and chemotherapy, 47(6), pp. 1943-7. Washington, D.C.: American Society for Microbiology 10.1128/AAC.47.6.1943-1947.2003
Täuber, MG (2003). [Infectious disease as a specialty--a Swiss perspective]. Deutsche medizinische Wochenschrift, 128(19), p. 1037. Stuttgart: Thieme 10.1055/s-2003-39098
Mühlemann, K; Matter, HC; Täuber, MG; Bodmer, T; Sentinel, Working Group (2003). Nationwide surveillance of nasopharyngeal Streptococcus pneumoniae isolates from children with respiratory infection, Switzerland, 1998-1999. Journal of infectious diseases, 187(4), pp. 589-596. Cary, N.C.: The University of Chicago Press 10.1086/367994
Cottagnoud, P; Cottagnoud, M; Täuber, MG (2003). Vancomycin acts synergistically with gentamicin against penicillin-resistant pneumococci by increasing the intracellular penetration of gentamicin. Antimicrobial agents and chemotherapy, 47(1), pp. 144-7. Washington, D.C.: American Society for Microbiology 10.1128/ACC.47.1.144-147.2003
Pfister, M; Zhang, L; Hammarlund-Udenaes, M; Sheiner, LB; Gerber, CM; Täuber, MG; Cottagnoud, P (2003). Modeling of transfer kinetics at the serum-cerebrospinal fluid barrier in rabbits with experimental meningitis: application to grepafloxacin. Antimicrobial agents and chemotherapy, 47(1), pp. 138-43. Washington, D.C.: American Society for Microbiology 10.1128/AAC.47.1.138-143.2003
Cottagnoud, P; Täuber, MG (2003). Fluoroquinolones in the Treatment of Meningitis. Current infectious disease reports, 5(4), pp. 329-336. Philadelphia, Pa.: Current Science 10.1007/s11908-003-0011-0
Piso, RJ; Rossi, M; Oehler, T; Nguyen, XM; Täuber, MG (2002). Fatal sepsis in an AIDS patient during therapy for Pneumocystis carinii pneumonia. Infection, 30(5), pp. 314-6. Heidelberg: Springer-Medizin-Verlag 10.1007/s15010-002-1159-5
Cottagnoud, P; Acosta, F; Cottagnoud, M; Täuber, MG (2002). Gemifloxacin is efficacious against penicillin-resistant and quinolone-resistant pneumococci in experimental meningitis. Antimicrobial agents and chemotherapy, 46(5), pp. 1607-9. Washington, D.C.: American Society for Microbiology 10.1128/AAC.46.5.1607-1609-2002
Zellweger, C; Täuber, MG (2002). [Antibiotic resistance: infections of the upper respiratory tract and bronchi. When are antibiotics necessary?]. Therapeutische Umschau, 59(1), pp. 21-9. Bern: Huber
Cottagnoud, P; Acosta, F; Cottagnoud, M; Täuber, MG (2002). Cefepime is efficacious against penicillin- and quinolone-resistant pneumococci in experimental meningitis. Journal of antimicrobial chemotherapy, 49(2), pp. 327-30. Oxford: Oxford University Press 10.1093/jac/49.2.327
Cottagnoud, P; Gerber, CM; Cottagnoud, M; Täuber, MG (2002). Gentamicin increases the efficacy of vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model. Antimicrobial agents and chemotherapy, 46(1), pp. 188-90. Washington, D.C.: American Society for Microbiology 10.1128/AAC.46.1.188-190.2002
Cottagnoud, P; Acosta, F; Cottagnoud, M; Pfister, M; Täuber, MG (2002). Efficacies of BMS 284756 against penicillin-sensitive, penicillin-resistant, and quinolone-resistant pneumococci in experimental meningitis. Antimicrobial agents and chemotherapy, 46(1), pp. 184-7. Washington, D.C.: American Society for Microbiology 10.1128/AAC.46.1.184-187.2002
Almli, LM; Hamrick, SE; Koshy, AA; Täuber, MG; Ferriero, DM (2001). Multiple pathways of neuroprotection against oxidative stress and excitotoxic injury in immature primary hippocampal neurons. Developmental brain research, 132(2), pp. 121-9. Amsterdam: Elsevier 10.1016/S0165-3806(01)00302-9
Dusch, H; Täuber, MG (2001). [Community-acquired pneumonia--pathogens and assessment]. Therapeutische Umschau, 58(10), pp. 575-81. Bern: Huber
Perrig, M; Acosta, F; Cottagnoud, M; Gerber, CM; Täuber, MG; Cottagnoud, P (2001). Efficacy of gatifloxacin alone and in combination with cefepime against penicillin-resistant Streptococcus pneumoniae in a rabbit meningitis model and in vitro. Journal of antimicrobial chemotherapy, 47(5), pp. 701-4. Oxford: Oxford University Press 10.1093/jac/47.5.701
Pfister, LA; Tureen, JH; Shaw, S; Christen, S; Ferriero, DM; Täuber, MG; Leib, Stephen L. (2000). Endothelin inhibition improves cerebral blood flow and is neuroprotective in pneumococcal meningitis. Annals of neurology, 47(3), pp. 329-335. Hoboken, N.J.: Wiley-Blackwell 10.1002/1531-8249(200003)47:3<329::AID-ANA8>3.3.CO;2-I
Täuber, MG (2000). Pneumonia due to resistant Streptococcus pneumoniae. Schweizerische medizinische Wochenschrift, 130(49), pp. 1873-9. Basel: B. Schwabe & Co.
Cottagnoud, P; Gerber, CM; Acosta, F; Cottagnoud, M; Neftel, K; Täuber, MG (2000). Linezolid against penicillin-sensitive and -resistant pneumococci in the rabbit meningitis model. Journal of antimicrobial chemotherapy, 46(6), pp. 981-5. Oxford: Oxford University Press 10.1093/jac/46.6.981
Gerber, CM; Tovar, L; Cottagnoud, M; Neftel, KA; Täuber, MG; Cottagnoud, P (2000). Grepafloxacin against penicillin-resistant pneumococci in the rabbit meningitis model. Journal of antimicrobial chemotherapy, 46(2), pp. 249-53. Oxford: Oxford University Press 10.1093/jac/46.2.249
Leib, Stephen L.; Täuber, MG (2000). [In search of strategies for preventing brain damage as a sequela of bacterial meningitis]. Schweizerische medizinische Wochenschrift, 130(24), pp. 928-35. Basel: B. Schwabe & Co.
Cottagnoud, P; Acosta, F; Cottagnoud, M; Neftel, K; Täuber, MG (2000). Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro. Antimicrobial agents and chemotherapy, 44(8), pp. 2179-81. Washington, D.C.: American Society for Microbiology 10.1128/AAC.44.8.2179-2181.2000
Guillet, EM; Täuber, MG (2000). [The hospitalized patient with fever and mental status changes]. Schweizerische medizinische Wochenschrift, 130(4), pp. 122-7. Basel: B. Schwabe & Co.
Böhlen, LM; Mühlemann, K; Dubuis, O; Aebi, C; Täuber, MG (2000). Outbreak among drug users caused by a clonal strain of group A streptococcus. Emerging infectious diseases, 6(2), pp. 175-179. Atlanta, Ga.: U.S. National Center for Infectious Diseases
Gerber, CM; Cottagnoud, M; Neftel, K; Täuber, MG; Cottagnoud, P (2000). Evaluation of cefepime alone and in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro. Journal of antimicrobial chemotherapy, 45(1), pp. 63-8. Oxford: Oxford University Press 10.1093/jac/45.1.63
Gerber, CM; Cottagnoud, M; Neftel, KA; Täuber, MG; Cottagnoud, P (1999). Meropenem alone and in combination with vancomycin in experimental meningitis caused by a penicillin-resistant pneumococcal strain. European journal of clinical microbiology & infectious diseases, 18(12), pp. 866-70. Berlin: Springer 10.1007/s100960050421
Täuber, MG; Hess, CW (1999). [Infections of the central nervous system--no problem for the doctor?]. Therapeutische Umschau, 56(11), pp. 629-30. Bern: Huber
Martin, JN; Perdreau-Remington, F; Kartalija, M; Pasi, OG; Webb, M; Gerberding, JL; Chambers, HF; Täuber, MG; Lee, BL (1999). A randomized clinical trial of mupirocin in the eradication of Staphylococcus aureus nasal carriage in human immunodeficiency virus disease. Journal of infectious diseases, 180(3), pp. 896-9. Cary, N.C.: Oxford University Press 10.1086/314949
Täuber, MG (1999). [Pneumonia: what's new?]. Schweizerische medizinische Wochenschrift, 129(14), pp. 563-9. Basel: B. Schwabe & Co.
Rodoni, D; Hänni, F; Gerber, CM; Cottagnoud, M; Neftel, K; Täuber, MG; Cottagnoud, P (1999). Trovafloxacin in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model. Antimicrobial agents and chemotherapy, 43(4), pp. 963-5. Washington, D.C.: American Society for Microbiology
Täuber, MG; Moser, B (1999). Cytokines and chemokines in meningeal inflammation: biology and clinical implications. Clinical infectious diseases, 28(1), pp. 1-11. Cary, N.C.: The University of Chicago Press 10.1086/515079
Mühlemann, K; Graf, S; Täuber, MG (1999). Streptococcus bovis clone causing two episodes of endocarditis 8 years apart. Journal of clinical microbiology, 37(3), pp. 862-3. Washington, D.C.: American Society for Microbiology
Täuber, MG (1998). Rabbit model of bacterial meningitis. Clinical microbiology and infection, 4(10), pp. 557-559. Oxford: Blackwell Publishing 10.1111/j.1469-0691.2007.01839.x
Kim, YS; Liu, Q; Chow, LL; Chambers, HF; Täuber, MG (1998). Comparative efficacy of trovafloxacin in experimental endocarditis caused by ciprofloxacin-sensitive, methicillin-resistant Staphylococcus aureus. Antimicrobial agents and chemotherapy, 42(12), pp. 3325-7. Washington, D.C.: American Society for Microbiology
Gilbert, DN; Lee, BL; Dworkin, RJ; Leggett, JL; Chambers, HF; Modin, G; Täuber, MG; Sande, MA (1998). A randomized comparison of the safety and efficacy of once-daily gentamicin or thrice-daily gentamicin in combination with ticarcillin-clavulanate. American journal of medicine, 105(3), pp. 182-91. Orlando, Fla.: Elsevier 10.1016/S0002-9343(98)00244-7
Täuber, MG (1997). To tap or not to tap? Clinical infectious diseases, 25(2), pp. 289-91. Cary, N.C.: Oxford University Press 10.1086/514530
Kim, YS; Liu, Q; Chow, LL; Täuber, MG (1997). Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae. Antimicrobial agents and chemotherapy, 41(5), pp. 1186-9. Washington, D.C.: American Society for Microbiology
Kim, YS; Täuber, MG (1996). Neurotoxicity of glia activated by gram-positive bacterial products depends on nitric oxide production. Infection and immunity, 64(8), pp. 3148-53. New York, N.Y.: American Society for Microbiology
Kartalija, M; Kaye, K; Tureen, JH; Liu, Q; Täuber, MG; Elliott, BR; Sande, MA (1996). Treatment of experimental cryptococcal meningitis with fluconazole: impact of dose and addition of flucytosine on mycologic and pathophysiologic outcome. Journal of infectious diseases, 173(5), pp. 1216-21. Cary, N.C.: Oxford University Press 10.1093/infdis/173.5.1216
Lee, BL; Täuber, MG; Sadler, B; Goldstein, D; Chambers, HF (1996). Atovaquone inhibits the glucuronidation and increases the plasma concentrations of zidovudine. Clinical pharmacology & therapeutics, 59(1), pp. 14-21. New York, N.Y.: Nature Publishing Group 10.1016/S0009-9236(96)90019-3
Kim, YS; Sheldon, RA; Elliott, BR; Liu, Q; Ferriero, DM; Täuber, MG (1995). Brain injury in experimental neonatal meningitis due to group B streptococci. Journal of neuropathology and experimental neurology, 54(4), pp. 531-9. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/00005072-199507000-00007
Kim, YS; Kennedy, S; Täuber, MG (1995). Toxicity of Streptococcus pneumoniae in neurons, astrocytes, and microglia in vitro. Journal of infectious diseases, 171(5), pp. 1363-8. Cary, N.C.: Oxford University Press 10.1093/infdis/171.5.1363
Kartalija, M; Kim, Y; White, ML; Nau, R; Tureen, JH; Täuber, MG (1995). Effect of a recombinant N-terminal fragment of bactericidal/permeability-increasing protein (rBPI23) on cerebrospinal fluid inflammation induced by endotoxin. Journal of infectious diseases, 171(4), pp. 948-53. Cary, N.C.: Oxford University Press 10.1093/infdis/171.4.948
Nau, R; Schmidt, T; Kaye, K; Froula, JL; Täuber, MG (1995). Quinolone antibiotics in therapy of experimental pneumococcal meningitis in rabbits. Antimicrobial agents and chemotherapy, 39(3), pp. 593-7. Washington, D.C.: American Society for Microbiology 10.1128/AAC.39.3.593
Pfister, HW; Fontana, A; Täuber, MG; Tomasz, A; Scheld, WM (1994). Mechanisms of brain injury in bacterial meningitis: workshop summary. Clinical infectious diseases, 19(3), pp. 463-79. Cary, N.C.: Oxford University Press 10.1093/clinids/19.3.463
Nau, R; Kaye, K; Sachdeva, M; Sande, ER; Täuber, MG (1994). Rifampin for therapy of experimental pneumococcal meningitis in rabbits. Antimicrobial agents and chemotherapy, 38(5), pp. 1186-9. Washington, D.C.: American Society for Microbiology 10.1128/AAC.38.5.1186
Täuber, MG; Zwahlen, A (1994). Animal models for meningitis. Methods in enzymology, 235(235), pp. 93-106. New York, N.Y.: Academic Press
Sullam, PM; Frank, U; Yeaman, MR; Täuber, MG; Bayer, AS; Chambers, HF (1993). Effect of thrombocytopenia on the early course of streptococcal endocarditis. Journal of infectious diseases, 168(4), pp. 910-4. Cary, N.C.: Oxford University Press 10.1093/infdis/168.4.910
Schmidt, T; Froula, J; Täuber, MG (1993). Clarithromycin lacks bactericidal activity in cerebrospinal fluid in experimental pneumococcal meningitis. Journal of antimicrobial chemotherapy, 32(4), pp. 627-32. Oxford: Oxford University Press 10.1093/jac/32.4.627
Täuber, MG; Sande, E; Fournier, MA; Tureen, JH; Sande, MA (1993). Fluid administration, brain edema, and cerebrospinal fluid lactate and glucose concentrations in experimental Escherichia coli meningitis. Journal of infectious diseases, 168(2), pp. 473-6. Cary, N.C.: Oxford University Press 10.1093/infdis/168.2.473
Schmidt, T; Täuber, MG (1993). Pharmacodynamics of antibiotics in the therapy of meningitis: infection model observations. Journal of antimicrobial chemotherapy, 31(Suppl D), pp. 61-70. Oxford: Oxford University Press 10.1093/jac/31.suppl_D.61
Guerra-Romero, L; Tureen, JH; Fournier, MA; Makrides, V; Täuber, MG (1993). Amino acids in cerebrospinal and brain interstitial fluid in experimental pneumococcal meningitis. Pediatric research, 33(5), pp. 510-3. New York, N.Y.: Nature Publishing Group 10.1203/00006450-199305000-00018
Täuber, MG; Ferriero, D; Kennedy, SL; Sheldon, RA; Guerra-Romero, L (1993). Brain levels of neuropeptide Y in experimental pneumococcal meningitis. Molecular and chemical neuropathology, 18(1-2), pp. 15-26. Clifton, N.J.: Humana Press 10.1007/BF03160019
O'Reilly, T; Kunz, S; Sande, E; Zak, O; Sande, MA; Täuber, MG (1992). Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin. Antimicrobial agents and chemotherapy, 36(12), pp. 2693-7. Washington, D.C.: American Society for Microbiology 10.1128/AAC.36.12.2693
Täuber, MG; Sachdeva, M; Kennedy, SL; Loetscher, H; Lesslauer, W (1992). Toxicity in neuronal cells caused by cerebrospinal fluid from pneumococcal and gram-negative meningitis. Journal of infectious diseases, 166(5), pp. 1045-50. Cary, N.C.: Oxford University Press 10.1093/infdis/166.5.1045
Guerra-Romero, L; Täuber, MG; Fournier, MA; Tureen, JH (1992). Lactate and glucose concentrations in brain interstitial fluid, cerebrospinal fluid, and serum during experimental pneumococcal meningitis. Journal of infectious diseases, 166(3), pp. 546-50. Cary, N.C.: Oxford University Press 10.1093/infdis/166.3.546
Täuber, MG; Kennedy, SL; Tureen, JH; Lowenstein, DH (1992). Experimental pneumococcal meningitis causes central nervous system pathology without inducing the 72-kd heat shock protein. American journal of pathology, 141(1), pp. 53-60. New York, N.Y.: Elsevier
Täuber, MG (1992). [Dexamethasone in bacterial meningitis]. Deutsche medizinische Wochenschrift, 117(26), pp. 1044-5. Stuttgart: Thieme
Tureen, JH; Täuber, MG; Sande, MA (1992). Effect of hydration status on cerebral blood flow and cerebrospinal fluid lactic acidosis in rabbits with experimental meningitis. Journal of clinical investigation, 89(3), pp. 947-53. Ann Arbor, Mich.: American Society for Clinical Investigation 10.1172/JCI115676
Guerra-Romero, L; Tureen, JH; Täuber, MG (1992). Pathogenesis of central nervous system injury in bacterial meningitis. Antibiotics and chemotherapy, 45(45), pp. 18-29. Basel: Karger
Lee, BL; Padula, AM; Täuber, MG; Chambers, HF; Sande, MA (1992). Oral SCH 39304 as primary, salvage, and maintenance therapy for cryptococcal meningitis in AIDS. Journal of acquired immune deficiency syndromes JAIDS, 5(6), pp. 600-4. Philadelphia, Pa.: Lippincott Williams & Wilkins
Guerra-Romero, L; Kennedy, SL; Fournier, MA; Tureen, JH; Täuber, MG (1991). Use of ampicillin-sulbactam for treatment of experimental meningitis caused by a beta-lactamase-producing strain of Escherichia coli K-1. Antimicrobial agents and chemotherapy, 35(10), pp. 2037-41. Washington, D.C.: American Society for Microbiology 10.1128/AAC.35.10.2037
Täuber, MG; Burroughs, M; Niemöller, UM; Kuster, H; Borschberg, U; Tuomanen, E (1991). Differences of pathophysiology in experimental meningitis caused by three strains of Streptococcus pneumoniae. Journal of infectious diseases, 163(4), pp. 806-11. Cary, N.C.: Oxford University Press 10.1093/infdis/163.4.806
Tureen, JH; Täuber, MG; Sande, MA (1991). Effect of indomethacin on the pathophysiology of experimental meningitis in rabbits. Journal of infectious diseases, 163(3), pp. 647-9. Cary, N.C.: Oxford University Press 10.1093/infdis/163.3.647
Baumann, R; Täuber, MG; Opravil, M; Hirschel, B; Kinloch, S; Chave, JP; Pletscher, M; Lüthy, R (1991). Combined treatment with zidovudine and lymphoblast interferon-alpha in patients with HIV-related Kaposi's sarcoma. Klinische Wochenschrift, 69(8), pp. 360-7. Berlin: Springer 10.1007/BF02115785
Täuber, MG; Sande, MA (1990). General principles of therapy of pyogenic meningitis. Infectious disease clinics of North America, 4(4), pp. 661-76. New York, N.Y.: Elsevier
Kern, W; Kennedy, SL; Sachdeva, M; Sande, ER; Gunderson, D; Täuber, MG (1990). Evaluation of piperacillin-tazobactam in experimental meningitis caused by a beta-lactamase-producing strain of K1-positive Escherichia coli. Antimicrobial agents and chemotherapy, 34(5), pp. 697-701. Washington, D.C.: American Society for Microbiology 10.1128/AAC.34.5.697
Täuber, MG; Sande, MA (1990). Pharmacodynamics of antibiotics in experimental bacterial meningitis--two sides to rapid bacterial killing in the cerebrospinal fluid. Scandinavian journal of infectious diseases, 74(74), pp. 173-178. Oslo: Informa Healthcare
Täuber, MG (1989). Brain edema, intracranial pressure and cerebral blood flow in bacterial meningitis. Pediatric infectious disease journal, 8(12), pp. 915-7. Hagerstown, Md.: Lippincott Williams & Wilkins
Täuber, MG; Sande, MA (1989). Dexamethasone in bacterial meningitis: increasing evidence for a beneficial effect. Pediatric infectious disease journal, 8(12), pp. 842-4. Hagerstown, Md.: Lippincott Williams & Wilkins
Sande, MA; Täuber, MG; Scheld, WM; McCracken, GH (1989). Pathophysiology of bacterial meningitis: summary of the workshop. Pediatric infectious disease journal, 8(12), pp. 929-33. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/00006454-198912000-00048
Courvoisier, S; Täuber, MG; Lüthy, R (1989). [Bisexuality and AIDS. Implications for heterosexual HIV infections in women]. Praxis - schweizerische Rundschau für Medizin, 78(17), pp. 486-93. Bern: Huber
Täuber, MG; Kunz, S; Zak, O; Sande, MA (1989). Influence of antibiotic dose, dosing interval, and duration of therapy on outcome in experimental pneumococcal meningitis in rabbits. Antimicrobial agents and chemotherapy, 33(4), pp. 418-23. Washington, D.C.: American Society for Microbiology 10.1128/AAC.33.4.418
Niemöller, UM; Täuber, MG (1989). Brain edema and increased intracranial pressure in the pathophysiology of bacterial meningitis. European journal of clinical microbiology & infectious diseases, 8(2), pp. 109-117. Berlin: Springer 10.1007/BF01963892
Fleep, M; Täuber, MG; Lüthy, R (1988). [Clinical aspects of HIV-associated diseases]. Therapeutische Umschau, 45(9), pp. 604-10. Bern: Huber
Garlando, F; Täuber, MG; Lüthy, R (1988). [Endocarditis prophylaxis with amoxicillin, clindamycin or erythromycin? Serum bacteriostatic and bactericidal effect against Streptococcus viridans]. Deutsche medizinische Wochenschrift, 113(27), pp. 1087-91. Stuttgart: Thieme 10.1055/s-2008-1067772
Täuber, MG; Borschberg, U; Sande, MA (1988). Influence of granulocytes on brain edema, intracranial pressure, and cerebrospinal fluid concentrations of lactate and protein in experimental meningitis. Journal of infectious diseases, 157(3), pp. 456-64. Cary, N.C.: Oxford University Press 10.1093/infdis/157.3.456
Jost, J; Täuber, MG; Lüthy, R; Siegenthaler, W (1988). [HIV-associated thrombocytopenia]. Schweizerische medizinische Wochenschrift, 118(6), pp. 206-12. Basel: B. Schwabe & Co.
Täuber, MG; Shibl, AM; Hackbarth, CJ; Larrick, JW; Sande, MA (1987). Antibiotic therapy, endotoxin concentration in cerebrospinal fluid, and brain edema in experimental Escherichia coli meningitis in rabbits. Journal of infectious diseases, 156(3), pp. 456-62. Cary, N.C.: Oxford University Press 10.1093/infdis/156.3.456
Chambers, HF; Morris, DL; Täuber, MG; Modin, G (1987). Cocaine use and the risk for endocarditis in intravenous drug users. Annals of internal medicine, 106(6), pp. 833-6. Philadelphia, Pa.: American College of Physicians
Terrier, B; Täuber, MG (1987). [Rare pathogens of skeletal infections and their relationship to special patient groups]. Praxis - schweizerische Rundschau für Medizin, 76(19), pp. 519-23. Bern: Huber
Täuber, MG (1987). [Skeletal infections--an interdisciplinary challenge]. Praxis - schweizerische Rundschau für Medizin, 76(19), p. 505. Bern: Huber
Kayser, FH; Täuber, MG (1987). [Diagnostic and microbiological aspects of skeletal infections]. Praxis - schweizerische Rundschau für Medizin, 76(19), pp. 524-7. Bern: Huber
Garlando, F; Rietiker, S; Täuber, MG; Flepp, M; Meier, B; Lüthy, R (1987). Single-dose ciprofloxacin at 100 versus 250 mg for treatment of uncomplicated urinary tract infections in women. Antimicrobial agents and chemotherapy, 31(2), pp. 354-6. Washington, D.C.: American Society for Microbiology 10.1128/AAC.31.2.354
Jost, J; Ledergerber, B; Täuber, MG (1986). [The HIV-antibody positive patient in general practice. Guidelines for rational diagnosis and treatment]. Praxis - schweizerische Rundschau für Medizin, 75(48), pp. 1454-7. Bern: Huber
Flepp, M; Täuber, MG (1986). [Opportunistic diseases in patients with HIV infection]. Praxis - schweizerische Rundschau für Medizin, 75(48), pp. 1445-50. Bern: Huber
Täuber, MG (1986). [Therapy of bacterial meningitis]. Deutsche medizinische Wochenschrift, 111(19), pp. 747-8. Stuttgart: Thieme 10.1055/s-2008-1068526
Täuber, MG (1986). [Diagnosis of bacterial meningitis]. Deutsche medizinische Wochenschrift, 111(19), pp. 745-6. Stuttgart: Thieme 10.1055/s-2008-1068525
Small, PM; Täuber, MG; Hackbarth, CJ; Sande, MA (1986). Influence of body temperature on bacterial growth rates in experimental pneumococcal meningitis in rabbits. Infection and immunity, 52(2), pp. 484-7. New York, N.Y.: American Society for Microbiology
Flepp, M; Täuber, MG; Lüthy, R; Frauchiger, B; Barandun, J; Schütze, M; Joller, H; Frey-Wettstein, M; Vetter, W; Siegenthaler, W (1986). [Transfusion-associated LAV/HTLV-III infections in Switzerland. Report of 2 cases]. Schweizerische medizinische Wochenschrift, 116(14), pp. 426-8. Basel: B. Schwabe & Co.
Täuber, MG; Brooks-Fournier, RA; Sande, MA (1986). Experimental models of CNS infections. Contributions to concepts of disease and treatment. Neurologic clinics, 4(1), pp. 249-64. New York, N.Y.: Elsevier
Täuber, MG (1985). [Antibiotic therapy of bacterial meningitis: principles and practical recommendations]. Praxis - schweizerische Rundschau für Medizin, 74(34), pp. 876-81. Bern: Huber
Garlando, F; Täuber, MG; Joos, B; Oelz, O; Lüthy, R (1985). Ciprofloxacin-induced hematuria. Infection, 13(4), pp. 177-8. Heidelberg: Springer-Medizin-Verlag 10.1007/BF01642807
Sullam, PM; Täuber, MG; Hackbarth, CJ; Chambers, HF; Scott, KG; Sande, MA (1985). Pefloxacin therapy for experimental endocarditis caused by methicillin-susceptible or methicillin-resistant strains of Staphylococcus aureus. Antimicrobial agents and chemotherapy, 27(5), pp. 685-7. Washington, D.C.: American Society for Microbiology 10.1128/AAC.27.5.685
Täuber, MG; Khayam-Bashi, H; Sande, MA (1985). Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. Journal of infectious diseases, 151(3), pp. 528-34. Cary, N.C.: Oxford University Press 10.1093/infdis/151.3.528
Sullam, PM; Drake, TA; Täuber, MG; Hackbarth, CJ; Sande, MA (1985). Influence of the developmental state of valvular lesions on the antimicrobial activity of cefotaxime in experimental enterococcal infections. Antimicrobial agents and chemotherapy, 27(3), pp. 320-3. Washington, D.C.: American Society for Microbiology 10.1128/AAC.27.3.320
Täuber, MG; Hackbarth, CJ; Scott, KG; Rusnak, MG; Sande, MA (1985). New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits. Antimicrobial agents and chemotherapy, 27(3), pp. 340-2. Washington, D.C.: American Society for Microbiology 10.1128/AAC.27.3.340
Sullam, PM; Täuber, MG; Hackbarth, CJ; Sande, MA (1985). Antimicrobial activity of gentamicin in experimental enterococcal endocarditis. Antimicrobial agents and chemotherapy, 27(2), pp. 224-6. Washington, D.C.: American Society for Microbiology 10.1128/AAC.27.2.224
Sullam, PM; Täuber, MG; Hackbarth, CJ; Sande, MA (1985). Therapeutic efficacy of teicoplanin in experimental enterococcal endocarditis. Antimicrobial agents and chemotherapy, 27(1), pp. 135-6. Washington, D.C.: American Society for Microbiology 10.1128/AAC.27.1.135
Täuber, MG; Sande, MA (1984). Principles in the treatment of bacterial meningitis. American journal of medicine, 76(5A), pp. 224-30. Orlando, Fla.: Elsevier 10.1016/0002-9343(84)90268-7
Täuber, MG; Sande, MA (1984). Landmark perspective: The impact of penicillin on the treatment of meningitis. JAMA - the journal of the American Medical Association, 251(14), pp. 1877-80. Chicago, Ill.: American Medical Association 10.1001/jama.251.14.1877
Täuber, MG; Zak, O; Scheld, WM; Hengstler, B; Sande, MA (1984). The postantibiotic effect in the treatment of experimental meningitis caused by Streptococcus pneumoniae in rabbits. Journal of infectious diseases, 149(4), pp. 575-83. Cary, N.C.: Oxford University Press 10.1093/infdis/149.4.575
Täuber, MG; Doroshow, CA; Hackbarth, CJ; Rusnak, MG; Drake, TA; Sande, MA (1984). Antibacterial activity of beta-lactam antibiotics in experimental meningitis due to Streptococcus pneumoniae. Journal of infectious diseases, 149(4), pp. 568-74. Cary, N.C.: Oxford University Press 10.1093/infdis/149.4.568
Täuber, MG; Sande, MA (1984). Pathogenesis of bacterial meningitis: contributions by experimental models in rabbits. Infection, 1(12), S3-10. Heidelberg: Springer-Medizin-Verlag 10.1007/BF01641732
